netFormulary NHS
Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust
 Search
 Formulary Chapter 13: Skin - Full Chapter
13.05.02  Expand sub section  Preparations for psoriasis
13.05.02  Expand sub section  Topical preparations for psoriasis
Coal Tar Solution 12%, Salicylic Acid 2%, precipitated Sulfur 4% (Sebco®)
View adult BNF View SPC online
First Choice
Green

40g, 100g

 
Coal tar lotion (Exorex®)
View adult BNF View SPC online
Formulary
Green
 
   
Shampoos (T/Gel®)
View adult BNF View SPC online
Formulary
Green

125ml, 250ml

 
   
Coal Tar 2% with Salicylic Acid 2%
View adult BNF View SPC online
Formulary
Green

ointment

 
   
Dithranol (Dithrocream®)
View adult BNF View SPC online
Formulary

Cream - 0.1%, 0.25%, 0.5%, 1.0%, 2.0%

 

1st line Dithranol preperations

 
   
Calcipotriol 50micrograms/g with Betamethasone 0.05% (Dovobet®)
View adult BNF View SPC online
Formulary
Green

Gel, ointment

 

1st line other topical preperations

 
   
Calcipotriol 50microgram/g, (0.005%) (Dovonex)
View adult BNF View SPC online
Formulary
Green

Ointment, scalp application

 
   
Calcipotriol and betamethasone dipropionate Enstilar Cutaneous Foam
View adult BNF View SPC online
Formulary
Green

60g foam

 
   
Dithranol with Salicylic Acid
(Indication: Chronic plaque psoriasis predominantly used as short contact treatment for outpatients coming in for daily treatments)
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Green

Dithranol 1% and salicyclic acid 2% in emulsifying ointment 100g

Dithranol 2% and salicyclic acid 2% in emulsifying ointment 100g

Dithranol 4% and salicyclic acid 2% in emulsifying ointment 100g

Dithranol 8% and salicyclic acid 2% in emulsifying ointment 100g

Dithranol 16% and salicyclic acid 2% in emulsifying ointment 100g

 
   
Coal tar strong solution 1%, 2.5% & 5% in emulsifying Ointment
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Green
 
Link  Special from secondary care. For more information see: Specials recommended by the British Association of dermatologists for Skin Disease.
   
Salicylic acid: in emulsifying ointment Salicyclic acid 2% in aqueous cream 100g (Salicylic acid)
(2%, 5%, 10% and 20%)
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Green
 
Link  Special from secondary care. For more information see: Specials recommended by the British Association of dermatologists for Skin Disease.
   
Tar Pomade Pomade containing 6% coal tar solution and salicylic acid 2% in an emulsifying ointment base (Tar Pomade)
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Green
 
Link  Special from secondary care. For more information see: Specials recommended by the British Association of dermatologists for Skin Disease.
   
Zinc & Coal Tar (White’s Tar Paste) Paste containing zinc oxide 6%, coal tar 6%, emulsifying wax 5%, starch 38% and yellow soft paraffin 45%. (Zinc & Coal Tar (White’s Tar Paste) )
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Green
 
   
Zinc and Salicylic Acid Paste BP (Half Strength Lassar’s Paste)
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Green
 
Link  Special from secondary care. For more information see: Specials recommended by the British Association of dermatologists for Skin Disease.
   
Dithranol in Full Strength Lassar’s Paste
View adult BNF View SPC online
Unlicensed Drug Unlicensed
Red

0.1%, 0.2%, 0.4%, 0.6%, 0.8%, 1%, 2%, 4%, 6%, 8%

 

 
Link  Special from secondary care. For more information see: Specials recommended by the British Association of dermatologists for Skin Disease.
   
13.05.02  Expand sub section  Oral retinoids for psoriasis
 ....
 Non Formulary Items
Alphosyl HC® cream

View adult BNF View SPC online
Non Formulary
 
Calcipotriol

View adult BNF View SPC online
Non Formulary
 
Calcitriol 3micrograms/g  (Silkis®)

View adult BNF View SPC online
Non Formulary
 
Coal Tar 10%  (Carbo-Dome®)

View adult BNF View SPC online
Non Formulary
 
Coal Tar in Lassars Paste

View adult BNF View SPC online
Non Formulary
 
Coal Tar in Unguentum M

View adult BNF View SPC online
Non Formulary
 
Coal Tar Solution 2.5%, Arachis (peanut) Oil extract of Coal Tar 7.5%, Tar 7.5%, Cade Oil 7.5%, Liqiud Paraffin 35%  (Polytar Emollient®)

View adult BNF View SPC online
Non Formulary
 
Dithranol  (Micanol®)

View adult BNF View SPC online
Non Formulary
 
Dithranol  (Psorin®)

View adult BNF View SPC online
Non Formulary
 
Dithranol Ointment BP

View adult BNF View SPC online
Non Formulary
 
Dithranol Paste BP

View adult BNF View SPC online
Non Formulary
 
Salicylic Acid 3% w/w, Sulphur 3% w/w in Aqueous Cream

View adult BNF View SPC online
Non Formulary
 
Salicylic Acid in White Soft Paraffin

View adult BNF View SPC online
Non Formulary
 
Tacalcitol  (Curatoderm®)

View adult BNF View SPC online
Non Formulary
 
Tars

View adult BNF View SPC online
Non Formulary
 
Tars

View adult BNF View SPC online
Non Formulary
 
Tars

View adult BNF View SPC online
Non Formulary
 
Tars  (Clinitar®)

View adult BNF View SPC online
Non Formulary
 
Tars  (Cocois®)

View adult BNF View SPC online
Non Formulary
 
Tars  (Psoriderm®)

View adult BNF View SPC online
Non Formulary
 
Tars  (Zinc and Coal Tar Paste®)

View adult BNF View SPC online
Non Formulary
 
Tars - bath preparations

View adult BNF View SPC online
Non Formulary
 
Tars - bath preparations  (Pinetarsol®)

View adult BNF View SPC online
Non Formulary
 
Tars - bath preparations  (Psoriderm®)

View adult BNF View SPC online
Non Formulary
 
Tazarotene 0.05%  (Zorac®)

View adult BNF View SPC online
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs for hospital use or use by a specialist within specialist centre only. Initiation and monitoring of treatment should remain under the total responsibility of the appropriate hospital clinician or specialist. These drugs should only be prescribed under the direct supervision of that clinician or specialist and are not suitable for shared care arrangements. The drug should be supplied via the hospital or specialist centre for the duration of treatment.   

Amber

These are specialist drugs which must be initiated by secondary care specialist prescribers, but with the potential to transfer prescribing to primary care within written and agreed shared care protocols and according to the agreed process for transfer of care. For these drugs, in order to ensure patient safety, some aspects of care must remain with the specialist due to their complexity e.g. monitoring of disease or drug response. Other more routine aspects can be transferred to the GP e.g. monitoring of adverse effects and supply of the medicine. The specific responsibilities of the specialist and GP are defined in the shared care agreement for each drug. Shared care agreements are still under development for some amber drugs. Until these are available, it would be expected that any shared care request from secondary care to a GP would be accompanied by written information which defines prescribing and monitoring responsibilities. The hospital specialist should also provide the GP with enough information and support to allow the safe transfer and ongoing management of prescribing into primary care.   

Green +

Drugs which should usually be initiated in secondary care, or by a specialist clinician, but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case.  

Green

These are defined as new and established drugs, which may be prescribed, initiated, changed or maintained on FP10 by the GP and, if appropriate, discontinued without recourse to secondary care. N.B. DRUGS NOT IDENTIFIED IN THE FORMULARY BY A RED, AMBER OR GREEN+ SYMBOL ARE CLASSIFIED AS GREEN.   

netFormulary